Principal Investigator
Richard Preston
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20260673
Clinical Trial Summary
A Phase 1, Parallel-Design, Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability Following a Single Subcutaneous Administration of VK2735 in Adults with Normal and Impaired Hepatic Function
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Alisa Danielyan
Phone Number
+1 (305) 2435930
Email
axd2423@miami.edu